Eli Lilly And recalls
Eli Lilly And appears in 5 official U.S. recall notices indexed by RecallRadar, most recently on 2024-04-24.
Company names are normalized from agency data (legal suffixes removed), so related firms may appear under separate pages.
Recall summary
| Recall notices | 5 |
|---|---|
| Published | 2018-11-21 to 2024-04-24 |
| By agency | FDA Drug (5) |
| By classification | Class II (3), Class I (1), Class III (1) |
| By status | terminated (4), completed (1) |
| Distribution named in notices | AL, AZ, CA, IN, KS, LA, MS, OH, OR, PR, TN, TX, US |
Recalls
- Sterile Diluent, HUMALOG U-100 (insulin lispro injection), HUMULIN R U-100 REGULAR (insulin human injection), Insulin Lispro Injection u-10…
FDA Drug · Class II · 2024-04-24 · Eli Lilly And
Reason: CGMP Deviations - Glucagon Emergency Kit for Low Blood Sugar, Glucagon for Injection, 1 mg per vial
FDA Drug · Class I · 2021-10-20 · Eli Lilly And
Reason: SUBPOTENT DRUG: Vial contained a liquid substance, instead of the expected powder substance. There was also a lack of full drug effect upon administration. - Trulicity (dulaglutide), 0.75 mg/0.5 mL, 4 Single-Dose Pens per box, Rx only, Eli Lilly and Company, Indianapolis, IN 46285, NDC 0002-1433-…
FDA Drug · Class II · 2021-09-01 · Eli Lilly And
Reason: Labeling: Label error on declared strength - autoinjector devices labeled as 0.75 mg / 0.5 mL actually contain 1.5 mg / 0.5 mL of product. - Zyprexa Intramuscular, Olanzapine for Injection, 10 MG per Single Use Vial, Rx only, Marketed by: Lilly USA, LLC, Indianapolis, IN 46285, N…
FDA Drug · Class II · 2021-08-18 · Eli Lilly And
Reason: cGMP deviations: Atypical appearance, decrease in size and change in color of the lyophilized cake of drug product. - ERBITUX CETUXIMAB Injection, 200 mg/100 mL (2 mg/mL), 100 mL per single-use vial, Rx only, Manufactured by: ImClone LLC, a wholly-owned sub…
FDA Drug · Class III · 2018-11-21 · Eli Lilly And
Reason: Labeling: Missing label; potential for missing primary container label on the vial.